Nashville Biosciences enters into agreement with BC Platforms

Singapore - BC Platforms, a world leader in secure genomic data management and analytics, announces an agreement with Na...

November 15, 2018 | Thursday | News
Sandoz to focus on more lucrative markets

Novartis’ Sandoz division recently announced that it was no longer pursuing US approval for Rixathon, its biosimil...

November 15, 2018 | Thursday | News
Grunenthal establishes commercial footprint in the US

Grunenthal has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint ...

November 14, 2018 | Wednesday | News
VIB accelerates therapeutic biologics discovery with Geneious Biologics

Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like m...

November 14, 2018 | Wednesday | News
Amgen's Repatha shows durable treatment effect in long-term study

Singapore – Amgen announced the final results from a five-year open-label study evaluating the abil...

November 13, 2018 | Tuesday | News
Athenahealth sale sealed for $5.5B

Singapore – P-E player Veritas Capital and hedge fund Elliott Management have teamed to purchase Athenahealth...

November 12, 2018 | Monday | News
WHO uncovers big variations in antibiotics consumption

According to a recent survey conducted by the World Health Organization (WHO), antibiotics are used far more in some cou...

November 12, 2018 | Monday | News
Thermo Fisher brings New Director to Board

Thermo Fisher Scientific Inc., the world leader in serving science, has elected Jim Mullen to its board of directors. Mu...

November 8, 2018 | Thursday | News
NICE recommends Vyxeos for specific secondary AML

Jazz Pharmaceuticals plc  announced that the National Institute for Health and Care Excellence (NICE) has publ...

November 8, 2018 | Thursday | News
AbbVie announces global patent license with Momenta

AbbVie has announced patent license agreements with Momenta over its proposed biosimilar adalimumab product. Under the t...

November 7, 2018 | Wednesday | News
Oncology Analytics raises $21M Series B financing led by Oak HC/FT

Oncology Analytics, a leading technology-enabled service company which provides health plans, providers and patients wit...

November 6, 2018 | Tuesday | News
US scientists create biodegradable scaffold to transplant stem cells

A group of scientists from Rutgers University-New Brunswick Rutgers has created a tiny, biodegradable scaffold to transp...

November 5, 2018 | Monday | News
Merck launches BioContinuum platform for Next-Gen process improvements

Merck, the vibrant science and technology company, has launched its new BioContinuum Platform to advance biotherapeutic ...

November 5, 2018 | Monday | News
Researchers use polygene scores to treat psychiatric disorders

Genetics can be used to predict a patient's response to antipsychotic drug treatment for schizophrenia, according to a r...

November 5, 2018 | Monday | News
Research shows vulnerability of brain hacking for memory manipulation

Singapore - In the future, cyberattackers may be able to exploit memory implants to steal, spy on, alter or control huma...

November 5, 2018 | Monday | News
FDA approves Pfizer's lung cancer drug

Pfizer recently announced that the U.S. Food and DrugAdministration (FDA) has aproved LORBRENA  a third-generation ...

November 5, 2018 | Monday | News
BioGX announces new partnerships in EMEA and Asia-Pacific

Amsterdam-based BioGX B.V., a subsidiary of Birmingham, Alabama based molecular diagnostics company BioGX, ann...

November 2, 2018 | Friday | News
Agilent introduces groundbreaking UV-Vis spectrophotometer

Agilent Technologies Inc. has introduced the Cary 3500 UV-Vis system, an innovative spectrophotometer designed to help l...

November 2, 2018 | Friday | News